Pharmaceuticals with Indacaterol and Glycopyrronium bromide
Notice title: Arzneimittel mit der Wirkstoffkombination Indacaterol und Glycopyrroniumbromid (ATC: R03AL04)
Discount agreements for finished pharmaceuticals with the active ingredient combination Indacaterol and Glycopyrronium bromide (ATC: R03AL04): Conclusion of non-exclusive contracts under an open-house model according to § 130a Abs. 8 SGB V, open to any qualified pharmaceutical company under the same conditions without individual negotiations. The earliest contract start is January 1, 2027, the maximum contract duration is 24 months, ending no later than December 31, 2028. Contracts may be terminated if the AOK Sachsen-Anhalt tenders exclusive contracts.
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 799989-2026HTML
- TED PDF — 799989-2026PDF
- TED XML — 799989-2026XML
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.